Literature DB >> 18542002

Myostatin is a procachectic growth factor during postnatal myogenesis.

Craig McFarlane1, Mridula Sharma, Ravi Kambadur.   

Abstract

PURPOSE OF REVIEW: To describe the most relevant recent observations concerning the molecular mechanisms behind myostatin-induced muscle wasting. RECENT
FINDINGS: The main theme of this review is to summarize the biology and function of myostatin. Myostatin is a secreted growth factor that negatively regulates muscle growth. While inactivation of myostatin leads to muscle growth in vivo, excess levels of myostatin induces cachectic-like muscle wasting. Molecular analyses reveal that excess levels of myostatin induce Atrogin-1 expression by reducing Akt phosphorylation and thereby increasing FoxO1 activity. Recent findings have further speculated that myostatin may also play a role in cardiac cachexia.
SUMMARY: As myostatin is a potent inducer of muscle wasting, antagonists to myostatin have been speculated to have great therapeutic value in alleviating muscle wasting. Indeed, myostatin peptide antagonists and antibodies have shown great promise in containing muscle loss in animal models of muscle wasting. Given the beneficial effects of myostatin antagonists in animal models, clinical trials are underway with myostatin antibodies, peptibodies and soluble receptor. Therefore, this review article on the role of myostatin in muscle wasting is highly relevant to current themes in muscle biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18542002     DOI: 10.1097/MCO.0b013e32830007e2

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  6 in total

1.  Conversion of mechanical force into TGF-β-mediated biochemical signals.

Authors:  Toru Maeda; Tomoya Sakabe; Ataru Sunaga; Keiko Sakai; Alexander L Rivera; Douglas R Keene; Takako Sasaki; Edward Stavnezer; Joseph Iannotti; Ronen Schweitzer; Dusko Ilic; Harihara Baskaran; Takao Sakai
Journal:  Curr Biol       Date:  2011-05-19       Impact factor: 10.834

2.  Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity.

Authors:  Sabeera Bonala; Sudarsanareddy Lokireddy; Harikumar Arigela; Serena Teng; Walter Wahli; Mridula Sharma; Craig McFarlane; Ravi Kambadur
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

3.  Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.

Authors:  Sudarsanareddy Lokireddy; Craig McFarlane; Xiaojia Ge; Huoming Zhang; Siu Kwan Sze; Mridula Sharma; Ravi Kambadur
Journal:  Mol Endocrinol       Date:  2011-09-29

4.  TGF-β inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II.

Authors:  Samantha Gardner; Damir Alzhanov; Paul Knollman; David Kuninger; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-11-24

Review 5.  Inflammatory burden and amino acid metabolism in cancer cachexia.

Authors:  William J Durham; Edgar Lichar Dillon; Melinda Sheffield-Moore
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

6.  Myostatin is a novel tumoral factor that induces cancer cachexia.

Authors:  Sudarsanareddy Lokireddy; Isuru Wijerupage Wijesoma; Sabeera Bonala; Meng Wei; Siu Kwan Sze; Craig McFarlane; Ravi Kambadur; Mridula Sharma
Journal:  Biochem J       Date:  2012-08-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.